Anika Therapeutics Inc.
Organization details
- Legal name
- Anika Therapeutics Inc.
- Former names
- Anika Research Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Bedford
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ANIK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000898437
- EIN
- 04-3145961
Board of directors
-
Cheryl R. Blanchard · Director · President, CEO, DirectorSince 2023
-
Gary P. Fischetti · DirectorSince 2023
-
Glenn R. Larsen · DirectorSince 2023
-
Jeffery S. Thompson · DirectorSince 2023
-
John B. Henneman III · DirectorSince 2023
-
Joseph H. Capper · DirectorSince 2024
-
Sheryl L. Conley · DirectorSince 2023
-
Stephen D. Griffin · Director · President and CEOSince 2026
-
Stephen Richard · DirectorSince 2023
-
Susan L. N. Vogt · DirectorSince 2023
-
William R. Jellison · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.3%
-
98.7%
-
99.4%
Board connections
5 of this board's directors also sit on 9 other boards. 8 are in the same sector.
-
Neuronetics Inc. Same sectorvia Joseph H. Capper and Sheryl L. Conley
-
Aprea Therapeutics Inc. Same sectorvia John B. Henneman III
- via William R. Jellison
-
Dare Bioscience Inc. Same sectorvia Cheryl R. Blanchard
-
Medtronic plc. Same sectorvia William R. Jellison
-
Orthofix Medical Inc. Same sectorvia John B. Henneman III
-
TELA Bio Inc. Same sectorvia Joseph H. Capper
-
Telix Pharmaceuticals Limited Same sectorvia William R. Jellison
-
Xilio Therapeutics Inc. Same sectorvia Cheryl R. Blanchard
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $264,308
- 4 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Gary P. Fischetti Director | Open-market purchase | +1,000 | $20.32 | $20,320 |
| Aug 3, 2026 | Gary P. Fischetti Director | Open-market purchase | +1,000 | $20.75 | $20,750 |
| Jun 18, 2026 | Gary P. Fischetti Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | John B. Henneman III Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Stephen Richard Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Joseph H. Capper Director | Grant or award | +10,402 | — | — |
| Jun 18, 2026 | Sheryl L. Conley Director | Grant or award | +10,402 | — | — |
| Jun 3, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Option exercise | +12,840 | — | — |
| Jun 3, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Shares withheld for tax | −3,769 | $14.41 | $54,311 |
| May 1, 2026 | John B. Henneman III Director | Open-market purchase | +5,000 | $14.66 | $73,300 |
| Apr 30, 2026 | Stephen D. Griffin Director, Officer (President and CEO) | Open-market purchase | +12,200 | $12.29 | $149,938 |
| Mar 15, 2026 | Colleran David Officer (EVP, General Counsel, Corp Sec) | Option exercise | +6,449 | — | — |
| Mar 15, 2026 | Cheryl R. Blanchard Director | Option exercise | +25,131 | — | — |
| Mar 15, 2026 | McLeod Ian Officer (SVP, CAO & Treasurer) | Option exercise | +2,658 | — | — |
| Mar 15, 2026 | Colleran David Officer (EVP, General Counsel, Corp Sec) | Shares withheld for tax | −1,893 | $14.20 | $26,881 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Anika Therapeutics Inc.
Who is the CEO of Anika Therapeutics Inc.?
Cheryl R. Blanchard is Anika Therapeutics Inc.'s President, CEO, Director.
How many directors are on Anika Therapeutics Inc.'s board?
Anika Therapeutics Inc.'s board has 11 directors: Cheryl R. Blanchard, Gary P. Fischetti, Glenn R. Larsen, Jeffery S. Thompson, John B. Henneman III, Joseph H. Capper, Sheryl L. Conley, Stephen D. Griffin, Stephen Richard, Susan L. N. Vogt and 1 other.
Are Anika Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Anika Therapeutics Inc. insiders bought $264,308 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="anika-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.